Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation

Neuroscience

Volumn 342, Issue , 2017, Pages 212-231

  Brummelte, S ^a   Mc Glanaghy, E ^b,c   Bonnin, A ^d   Oberlander, T F ^b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

5 HT; epigenetics; fetal development; maternal depression; neurodevelopment; SSRI exposure

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; DOPAMINE; GLUCOCORTICOID RECEPTOR; NORADRENALIN; REELIN; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ADAPTIVE BEHAVIOR; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN GROWTH; CELL MIGRATION; CELL PROLIFERATION; CHILD ABUSE; CHRONIC STRESS; COPING BEHAVIOR; DEPRESSION; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; EXECUTIVE FUNCTION; FETUS DEVELOPMENT; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; LIFESPAN; MENTAL DISEASE; MENTAL HEALTH; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NERVE ENDING; NEUROMODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUERPERAL DEPRESSION; REVIEW; RISK FACTOR; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION; SOCIAL EVOLUTION; SOMATOSENSORY CORTEX; STEM CELL; ANIMAL; BRAIN; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; HUMANS; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 84962265116     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.02.037     Document Type: Review

References (219)

1. Alenina, N., Kikic, D., Todiras, M., Mosienko, V., Qadri, F., Plehm, R., Boye, P., Vilianovitch, L., Sohr, R., Tenner, K., Hortnagl, H., Bader, M., Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci U S A 106 (2009), 10332–10337.
2. Allister, L., Lester, B.M., Carr, S., Liu, J., The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation. Dev Neuropsychol 20 (2001), 639–651.
3. Altieri, S.C., Yang, H., O'Brien, H.J., Redwine, H.M., Senturk, D., Hensler, J.G., Andrews, A.M., Perinatal vs genetic programming of serotonin states associated with anxiety. Neuropsychopharmacology 40:6 (2015), 1456–1470.
4. Andrade, S.E., Raebel, M.A., Brown, J., Lane, K., Livingston, J., Boudreau, D., Rolnick, S.J., Roblin, D., Smith, D.H., Willy, M.E., Staffa, J.A., Platt, R., Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 198 (2008), 194–195.
5. Ansorge, M.S., Zhou, M., Lira, A., Hen, R., Gingrich, J.A., Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306 (2004), 879–881.
6. Ansorge, M.S., Morelli, E., Gingrich, J.A., Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 28 (2008), 199–207.
7. Azmitia, E.C., Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res Bull 56 (2001), 413–424.
8. Bairy, K.L., Madhyastha, S., Ashok, K.P., Bairy, I., Malini, S., Developmental and behavioral consequences of prenatal fluoxetine. Pharmacology 79 (2007), 1–11.
9. Banasr, M., Hery, M., Printemps, R., Daszuta, A., Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 29 (2004), 450–460.
10. Barden, N., Reul, J.M., Holsboer, F., Do antidepressants stabilize mood through actions on the hypothalamic-pituitary–adrenocortical system?. Trends Neurosci 18 (1995), 6–11.
11. Barker, D.J., Intrauterine programming of adult disease. Mol Med Today 1 (1995), 418–423.
12. Beach, S.R.H., Brody, G.H., Todorov, A.A., Gunter, T.D., Philibert, R.A., Methylation at SLC6A4 is linked to family history of child abuse: an examination of the Iowa Adoptee sample. Am J Med Genet B Neuropsychiatr Genet 153B (2010), 710–713.
13. Belsky, J., Pluess, M., Beyond diathesis stress: differential susceptibility to environmental influences. Psychol Bull 135 (2009), 885–908.
14. Bhuiyan, M., Petropoulos, S., Gibb, W., Matthews, S.G., Sertraline alters multidrug resistance phosphoglycoprotein activity in the mouse placenta and fetal blood–brain barrier. Reprod Sci 19 (2012), 407–415.
15. Blier, P., Bergeron, R., Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15 (1995), 217–222.
16. Bonnin, A., Levitt, P., Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 197 (2011), 1–7.
17. Bonnin, A., Levitt, P., Placental source for 5-HT that tunes fetal brain development. Neuropsychopharmacology 37 (2012), 299–300.
18. Bonnin, A., Torii, M., Wang, L., Rakic, P., Levitt, P., Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci 10 (2007), 588–597.
19. Bonnin, A., Goeden, N., Chen, K., Wilson, M.L., King, J., Shih, J.C., Blakely, R.D., Deneris, E.S., Levitt, P., A transient placental source of serotonin for the fetal forebrain. Nature 472 (2011), 347–350.
20. Booij, L., Wang, D., Levesque, M.L., Tremblay, R.E., Szyf, M., Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression. Philos Trans R Soc Lond B Biol Sci, 368, 2013, 20120251.
21. Booij, L.M., Carballedo, A., Frey, E.M., Morris, D., Dymov, S., Vaisheva, F., Ly, V., Fahey, C., Meaney, J., Gill, M., Frodl, T., DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls. PLoS One, 10, 2015, e0119061.
22. Booij, L., Tremblay, R.E., Szyf, M., Benkelfa, C., Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology. J Psychiatry Neurosci 40 (2015), 5–18.
23. Boukhris, T., Sheehy, O., Mottron, L., Berard, A., Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr 170:2 (2016), 117–124.
24. Boyce, W.T., Ellis, B.J., Biological sensitivity to context: I. An evolutionary–developmental theory of the origins and functions of stress reactivity. Dev Psychopathol 17 (2005), 271–301.
25. Brezun, J.M., Daszuta, A., Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 89 (1999), 999–1002.
26. Brezun, J.M., Daszuta, A., Serotonergic reinnervation reverses lesion-induced decreases in PSA-NCAM labeling and proliferation of hippocampal cells in adult rats. Hippocampus 10 (2000), 37–46.
27. Brummelte, S., Pawluski, J.L., Galea, L.A., High post-partum levels of corticosterone given to dams influence postnatal hippocampal cell proliferation and behavior of offspring: a model of post-partum stress and possible depression. Horm Behav 50 (2006), 370–382.
28. Brummelte, S., Galea, L.A.M., Devlin, A.M., Oberlander, T.F., Antidepressant use during pregnancy and serotonin transporter genotype (SLC6A4) Affect newborn serum reelin levels. Dev Psychobiol, 2012.
29. Burmeister, M., McInnis, M.G., Zollner, S., Psychiatric genetics: progress amid controversy. Nat Rev Genet 9 (2008), 527–540.
30. Buznikov, G.A., The action of neurotransmitters and related substances on early embryogenesis. Pharmacol Ther 25 (1984), 23–59.
31. Caldji, C., Hellstrom, I.C., Zhang, T.Y., Diorio, J., Meaney, M.J., Environmental regulation of the neural epigenome. FEBS Lett 585 (2011), 2049–2058.
32. Cases, O., Vitalis, T., Seif, I., De, M.E., Sotelo, C., Gaspar, P., Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 16 (1996), 297–307.
33. Casper, R.C., Fleisher, B.E., Lee-Ancajas, J.C., Gilles, A., Gaylor, E., DeBattista, A., Hoyme, H.E., Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 142 (2003), 402–408.
34. Caspi, A., Moffitt, T.E., Opinion – gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7 (2006), 583–590.
35. Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., Poulton, R., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003), 386–389.
36. Chameau, P., Inta, D., Vitalis, T., Monyer, H., Wadman, W.J., Van Hooft, J.A., The N-terminal region of reelin regulates postnatal dendritic maturation of cortical pyramidal neurons. Proc Natl Acad Sci U S A 106 (2009), 7227–7232.
37. Chaouloff, F., Berton, O., Mormede, P., Serotonin and stress. Neuropsychopharmacology 21 (1999), 28S–32S.
38. Charney, D.S., Manji, H.K., Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE, 2004, 2004, re5.
39. Chrousos, G.P., The role of stress and the hypothalamic-pituitary–adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obes Relat Metab Disord 24:Suppl 2 (2000), S50–S55.
40. Chugani, D.C., Niimura, K., Chaturvedi, S., Muzik, O., Fakhouri, M., Lee, M.L., Chugani, H.T., Increased brain serotonin synthesis in migraine. Neurology 53 (1999), 1473–1479.
41. Clements, C.C., Castro, V.M., Blumenthal, S.R., Rosenfield, H.R., Murphy, S.N., Fava, M., Erb, J.L., Churchill, S.E., Kaimal, A.J., Doyle, A.E., Robinson, E.B., Smoller, J.W., Kohane, I.S., Perlis, R.H., Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol Psychiatry 20 (2015), 727–734.
42. Cohen, L.S., Altshuler, L.L., Harlow, B.L., Nonacs, R., Newport, D.J., Viguera, A.C., Suri, R., Burt, V.K., Hendrick, V., Reminick, A.M., Loughead, A., Vitonis, A.F., Stowe, Z.N., Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295 (2006), 499–507.
43. Collier, D.A., Stober, G., Li, T., Heils, A., Catalano, M., Di Bella, D., Arranz, M.J., Murray, R.M., Vallada, H.P., Bengel, D., Muller, C.R., Roberts, G.W., Smeraldi, E., Kirov, G., Sham, P., Lesch, K.P., A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1 (1996), 453–460.
44. Connell, S., Karikari, C., Hohmann, C.F., Sex-specific development of cortical monoamine levels in mouse. Brain Res Dev Brain Res 151 (2004), 187–191.
45. Cooper, W.O., Willy, M.E., Pont, S.J., Ray, W.A., Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 196 (2007), 544–545.
46. Croen, L.A., Grether, J.K., Yoshida, C.K., Odouli, R., Hendrick, V., Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 68 (2011), 1104–1112.
47. David, S.P., Murthy, N.V., Rabiner, E.A., Munafo, M.R., Johnstone, E.C., Jacob, R., Walton, R.T., Grasby, P.M., A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 25 (2005), 2586–2590.
48. DE Montigny, C., Chaput, Y., Blier, P., Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 51:Suppl B (1990), 4–8.
49. Devlin, A.M., Brain, U., Austin, J., Oberlander, T.F., Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One, 5, 2010, e12201.
50. DiPietro, J.A., Hodgson, D.M., Costigan, K.A., Johnson, T.R., Fetal antecedents of infant temperament. Child Dev 67 (1996), 2568–2583.
51. Drevets, W.C., Frank, E., Price, J.C., Kupfer, D.J., Holt, D., Greer, P.J., Huang, Y., Gautier, C., Mathis, C., PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46 (1999), 1375–1387.
52. Duncan, L.E., Paying attention to all results, positive and negative. J Am Acad Child Adolesc Psychiatry 52 (2013), 462–465.
53. El, M.H., White, T.J., van der Knaap, N.J., Homberg, J.R., Fernandez, G., Schoemaker, N.K., Jaddoe, V.W., Hofman, A., Verhulst, F.C., Hudziak, J.J., Stricker, B.H., Tiemeier, H., Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry 205 (2014), 95–102.
54. Eley, T.C., Sugden, K., Corsico, A., Gregory, A.M., Sham, P., McGuffin, P., Plomin, R., Craig, I.W., Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry 9 (2004), 908–915.
55. Essex, M.J., Boyce, W.T., Hertzman, C., Lam, L.L., Armstrong, J.M., Neumann, S.M., Kobor, M.S., Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence. Child Dev 84 (2013), 58–75.
56. Field, T., Diego, M., Hernandez-Reif, M., Vera, Y., Gil, K., Schanberg, S., Kuhn, C., Gonzalez-Garcia, A., Prenatal maternal biochemistry predicts neonatal biochemistry. Int J Neurosci 114 (2004), 933–945.
57. Field, T., Diego, M., Dieter, J., Hernandez-Reif, M., Schanberg, S., Kuhn, C., Yando, R., Bendell, D., Prenatal depression effects on the fetus and the newborn. Infant Behav Dev 27 (2004), 216–229.
58. Field, T., Diego, M., Hernandez-Reif, M., Figueiredo, B., Deeds, O., Ascencio, A., Schanberg, S., Kuhn, C., Prenatal dopamine and neonatal behavior and biochemistry. Infant Behav Dev 31 (2008), 590–593.
59. Fox, N.A., Nichols, K.E., Henderson, H.A., Rubin, K., Schmidt, L., Hamer, D., Ernst, M., Pine, D.S., Evidence for a gene-environment interaction in predicting behavioral inhibition in middle childhood. Psychol Sci 16 (2005), 921–926.
60. Fox, E., Ridgewell, A., Ashwin, C., Looking on the bright side: biased attention and the human serotonin transporter gene. Proc Biol Sci 276 (2009), 1747–1751.
61. Frodl, T., Szyf, M., Carballedo, A., Ly, V., Dymov, S., Vaisheva, F., Morris, D., Fahey, C., Meaney, J., Gill, M., Booij, L., DNA methylation of the serotonin transporter gene (SLC6A4) is associated with brain function involved in processing emotional stimuli. J Psychiatry Neurosci 40 (2015), 296–305.
62. Fuller, R.W., Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions. Ann NY Acad Sci 780 (1996), 176–184.
63. Galbally, M., Lewis, A.J., Buist, A., Child developmental outcomes in preschool children following antidepressant exposure in pregnancy. Aust N Z J Psychiatry 49 (2015), 642–650.
64. Gaspar, P., Cases, O., Maroteaux, L., The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4 (2003), 1002–1012.
65. Gentile, S., Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?. J Affect Disord 182 (2015), 132–137.
66. Gentile, S., Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience 342 (2017), 154–166.
67. Gidaya, N., Lee, B., Burstyn, I., Yudell, M., Mortensen, E., Newschaffer, C., In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. J Autism Dev Disord 44 (2014), 2558–2567.
68. Gingrich, J.A., Hen, R., Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 155 (2001), 1–10.
69. Glennon, R.A., Dukat, M., Westkaemper, R.B., Serotonin receptor subtypes and ligands. Bloom, F.E., Kupfer, D.J., (eds.) Psychopharmacology-4th generation of progress, 1995, Raven Press, New York, New York.
70. Glover, V., Annual research review: prenatal stress and the origins of psychopathology: an evolutionary perspective. J Child Psychol Psychiatry 52 (2011), 356–367.
71. Gluckman, P.D., Hanson, M.A., Spencer, H.G., Predictive adaptive responses and human evolution. Trends Ecol Evol 20 (2005), 527–533.
72. Gluckman, P.D., Hanson, M.A., Beedle, A.S., Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol 19 (2007), 1–19.
73. Gobbi, G., Murphy, D.L., Lesch, K., Blier, P., Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Ther 296 (2001), 987–995.
74. Hanley, G.E., Oberlander, T.F., Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a “social teratogen” or moderator of developmental risk?. Birth Defects Res A Clin Mol Teratol 94 (2012), 651–659.
75. Hanley, G.E., Brain, U., Oberlander, T.F., Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Hum Dev 89 (2013), 519–524.
76. Hanley, G.E., Brain, U., Oberlander, T.F., Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior. Pediatr Res 78 (2015), 174–180.
77. Hansen, H.H., Sanchez, C., Meier, E., Neonatal administration of the selective serotonin reuptake inhibitor Lu 10–134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression?. J Pharmacol Exp Ther 283 (1997), 1333–1341.
78. Hariri, A.R., Holmes, A., Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 10 (2006), 182–191.
79. Harrington, R.A., Lee, L.C., Crum, R.M., Zimmerman, A.W., Hertz-Picciotto, I., Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics 133 (2014), e1241–e1248.
80. Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., Bengel, D., Lesch, K.P., Allelic variation of human serotonin transporter gene expression. J Neurochem 66 (1996), 2621–2624.
81. Hendricks, T.J., Fyodorov, D.V., Wegman, L.J., Lelutiu, N.B., Pehek, E.A., Yamamoto, B., Silver, J., Weeber, E.J., Sweatt, J.D., Deneris, E.S., Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 37 (2003), 233–247.
82. Hensler, J.G., Serotonergic modulation of the limbic system. Neurosci Biobehav Rev 30 (2006), 203–214.
83. Hertzman, C., Boyce, T., How experience gets under the skin to create gradients in developmental health. Annu Rev Public Health 31 (2010), 329–347.
84. Hilli, J., Heikkinen, T., Rontu, R., Lehtimaki, T., Kishida, I., Aklillu, E., Bertilsson, L., Vahlberg, T., Laine, K., MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs. Eur Neuropsychopharmacol 19 (2009), 363–370.
85. Holloway, T., Gonzalez-Maeso, J., Epigenetic mechanisms of serotonin signaling. ACS Chem Neurosci 6 (2015), 1099–1109.
86. Holmes, A., Li, Q., Murphy, D.L., Gold, E., Crawley, J.N., Abnormal anxiety-related behaviour in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2 (2003), 365–380.
87. Holmes, A., Murphy, D.L., Crawley, J.N., Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry 54 (2003), 953–959.
88. Homberg, J.R., Contet, C., Deciphering the interaction of the corticotropin-releasing factor and serotonin brain systems in anxiety-related disorders. J Neurosci 29 (2009), 13743–13745.
89. Homberg, J.R., Lesch, K.P., Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry 69 (2011), 513–519.
90. Homberg, J., Mudde, J., Braam, B., Ellenbroek, B., Cuppen, E., Joles, J.A., Blood pressure in mutant rats lacking the 5-hydroxytryptamine transporter. Hypertension 48 (2006), e115–e116.
91. Homberg, J.R., Schubert, D., Gaspar, P., New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol Sci 31 (2010), 60–65.
92. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R., Humphrey, P.P., International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46 (1994), 157–203.
93. Huang, Y., Xu, H., Li, H., Yang, H., Chen, Y., Shi, X., Pre-gestational stress reduces the ratio of 5-HIAA to 5-HT and the expression of 5-HT1A receptor and serotonin transporter in the brain of foetal rat. BMC Neurosci, 13, 2012, 22.
94. Ikeda, Y., Terashima, T., Expression of reelin, the gene responsible for the reeler mutation, in embryonic development and adulthood in the mouse. Dev Dyn 210 (1997), 157–172.
95. Imoto, Y., Kira, T., Sukeno, M., Nishitani, N., Nagayasu, K., Nakagawa, T., Kaneko, S., Kobayashi, K., Segi-Nishida, E., Role of the 5-HT4 receptor in chronic fluoxetine treatment-induced neurogenic activity and granule cell dematuration in the dentate gyrus. Mol Brain, 8, 2015, 29.
96. Ishiwata, H., Shiga, T., Okado, N., Selective serotonin reuptake inhibitor treatment of early postnatal mice reverses their prenatal stress-induced brain dysfunction. Neuroscience 133 (2005), 893–901.
97. Janusonis, S., Gluncic, V., Rakic, P., Early serotonergic projections to Cajal-Retzius cells: relevance for cortical development. J Neurosci 24 (2004), 1652–1659.
98. Kalueff, A.V., Olivier, J.D., Nonkes, L.J., Homberg, J.R., Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev 34 (2010), 373–386.
99. Kang, H.J., Kim, J.M., Stewart, R., Kim, S.Y., Bae, K.Y., Kim, S.W., Shin, I.S., Shin, M.G., Yoon, J.S., Association of SLC6A4 methylation with early adversity, characteristics and outcomes in depression. Prog Neuropsychopharmacol Biol Psychiatry 44 (2013), 23–28.
100. Karg, K., Burmeister, M., Shedden, K., Sen, S., The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 68 (2011), 444–454.
101. Kendler, K.S., “A gene for...”: the nature of gene action in psychiatric disorders. Am J Psychiatry 162 (2005), 1243–1252.
102. Kendler, K.S., Kuhn, J.W., Vittum, J., Prescott, C.A., Riley, B., The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 62 (2005), 529–535.
103. Kim, J., Riggs, K.W., Misri, S., Kent, N., Oberlander, T.F., Grunau, R.E., Fitzgerald, C., Rurak, D.W., Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. Br J Clin Pharmacol 61 (2006), 155–163.
104. Kindt, K.S., Tam, T., Whiteman, S., Schafer, W.R., Serotonin promotes G(o)-dependent neuronal migration in Caenorhabditis elegans. Curr Biol 12 (2002), 1738–1747.
105. Kinnally, E.L., Capitanio, J.P., Leibel, R., Deng, L., LeDuc, C., Haghighi, F., Mann, J.J., Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques. Genes Brain Behav 9 (2010), 575–582.
106. Kiryanova, V., McAllister, B.B., Dyck, R.H., Long-term outcomes of developmental exposure to fluoxetine: a review of the animal literature. Dev Neurosci 35 (2013), 437–439.
107. Knaepen, L., Rayen, I., Charlier, T.D., Fillet, M., Houbart, V., van, K.M., Steinbusch, H.W., Patijn, J., Tibboel, D., Joosten, E.A., Pawluski, J.L., Developmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in Sprague–Dawley rat offspring. PLoS One, 8, 2013, e57608.
108. Koenen, K.C., Uddin, M., Chang, S.C., Aiello, A.E., Wildman, D.E., Goldmann, E., Galea, S., SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depress Anxiety 28 (2011), 639–647.
109. Laine, K., Heikkinen, T., Ekblad, U., Kero, P., Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 60 (2003), 720–726.
110. Lauder, J.M., Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Ann NY Acad Sci 600 (1990), 297–313.
111. Lauder, J.M., Krebs, H., Effects of p-chlorophenylalanine on time of neuronal origin during embryogenesis in the rat. Brain Res 107 (1976), 638–644.
112. Lesch, K.P., Linking emotion to the social brain. The role of the serotonin transporter in human social behaviour. EMBO Rep 8 (2007), S24–S29.
113. Lesch, K.P., When the serotonin transporter gene meets adversity: the contribution of animal models to understanding epigenetic mechanisms in affective disorders and resilience. Curr Top Behav Neurosci 7 (2011), 251–280.
114. Levitt, P., Serotonin and the autisms: a red flag or a red herring?. Arch Gen Psychiatry, 2011.
115. Liao, C.C., Lee, L.J., Neonatal fluoxetine exposure affects the action potential properties and dendritic development in cortical subplate neurons of rats. Toxicol Lett 207 (2011), 314–321.
116. Louik, C., Lin, A.E., Werler, M.M., Hernandez-Diaz, S., Mitchell, A.A., First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356 (2007), 2675–2683.
117. Lowry, C.A., Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary–adrenal axis. J Neuroendocrinol 14 (2002), 911–923.
118. Luddington, N.S., Mandadapu, A., Husk, M., El-Mallakh, R.S., Clinical implications of genetic variation in the serotonin transporter promoter region: a review. Prim Care Companion J Clin Psychiatry 11 (2009), 93–102.
119. Lupien, S.J., McEwen, B.S., Gunnar, M.R., Heim, C., Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10 (2009), 434–445.
120. Maciag, D., Simpson, K.L., Coppinger, D., Lu, Y., Wang, Y., Lin, R.C., Paul, I.A., Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31 (2006), 47–57.
121. Maciag, D., Williams, L., Coppinger, D., Paul, I.A., Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment. Eur J Pharmacol 532 (2006), 265–269.
122. Mahar, I., Bambico, F.R., Mechawar, N., Nobrega, J.N., Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev 38 (2014), 173–192.
123. Man, K.K., Tong, H.H., Wong, L.Y., Chan, E.W., Simonoff, E., Wong, I.C., Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: a systematic review and meta-analysis of observational studies. Neurosci Biobehav Rev 49 (2015), 82–89.
124. McEwen, B.S., Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 54 (2005), 20–23.
125. McGowan, P.O., Sasaki, A., D'Alessio, A.C., Dymov, S., Labonte, B., Szyf, M., Turecki, G., Meaney, M.J., Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12 (2009), 342–348.
126. Meyer, G., Perez-Garcia, C.G., Abraham, H., Caput, D., Expression of p73 and Reelin in the developing human cortex. J Neurosci 22 (2002), 4973–4986.
127. Migliarini, S., Pacini, G., Pelosi, B., Lunardi, G., Pasqualetti, M., Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Mol Psychiatry 18 (2013), 1106–1118.
128. Mileva-Seitz, V., Kennedy, J., Atkinson, L., Steiner, M., Levitan, R., Matthews, S.G., Meaney, M.J., Sokolowski, M.B., Fleming, A.S., Serotonin transporter allelic variation in mothers predicts maternal sensitivity, behavior and attitudes toward 6-month-old infants. Genes Brain Behav 10 (2011), 325–333.
129. Miyagawa, K., Tsuji, M., Fujimori, K., Saito, Y., Takeda, H., Prenatal stress induces anxiety-like behavior together with the disruption of central serotonin neurons in mice. Neurosci Res 70 (2011), 111–117.
130. Moffitt, T.E., Caspi, A., Rutter, M., Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 62 (2005), 473–481.
131. Monk, C., Fifer, W.P., Myers, M.M., Sloan, R.P., Trien, L., Hurtado, A., Maternal stress responses and anxiety during pregnancy: effects on fetal heart rate. Dev Psychobiol 36 (2000), 67–77.
132. Mooney-Leber, S., Kott, J.M., Shoubah, F.A., Perrine, S.A., Brummelte, S., Effects of in utero antidepressant (sertraline) exposure on offspring outcome in an animal model of maternal stress and depression. 2014, Society for Neuroscience Meeting Poster 347.14, Washington, DC, USA.
133. Morelli, E., Moore, H., Rebello, T.J., Gray, N., Steele, K., Esposito, E., Gingrich, J.A., Ansorge, M.S., Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction. J Neurosci 31 (2011), 15742–15750.
134. Morrison, J.L., Chien, C., Gruber, N., Rurak, D., Riggs, W., Fetal behavioural state changes following maternal fluoxetine infusion in sheep. Brain Res Dev Brain Res 131 (2001), 47–56.
135. Moses-Kolko, E.L., Bogen, D., Perel, J., Bregar, A., Uhl, K., Levin, B., Wisner, K.L., Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293 (2005), 2372–2383.
136. Mueller, B.R., Bale, T.L., Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci 28 (2008), 9055–9065.
137. Mueller, A., Brocke, B., Fries, E., Lesch, K.P., Kirschbaum, C., The role of the serotonin transporter polymorphism for the endocrine stress response in newborns. Psychoneuroendocrinology 35 (2010), 289–296.
138. Munafo, M.R., Durrant, C., Lewis, G., Flint, J., Gene + environment interactions at the serotonin transporter locus. Biol Psychiatry 65 (2009), 211–219.
139. Murphy, D.L., Fox, M.A., Timpano, K.R., Moya, P., Ren-Patterson, R., Andrews, A.M., Holmes, A., Watts, S.W., Wendland, J.R., Lesch, K.-P., How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology 55 (2008), 932–960.
140. Murphy Paul, A., Origins: how the nine months before birth shape the rest of our lives. 2010, Free Press, New York.
141. Nordquist, N., Oreland, L., Serotonin, genetic variability, behaviour, and psychiatric disorders–a review. Ups J Med Sci 115 (2010), 2–10.
142. Nulman, I., Rovet, J., Stewart, D.E., Wolpin, J., Gardner, H.A., Theis, J.G., Kulin, N., Koren, G., Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336 (1997), 258–262.
143. Oberlander, T.F., Fetal serotonin signaling: setting pathways for early childhood development and behavior. J Adolesc Health 51 (2012), S9–S16.
144. Oberlander, T.F., Eckstein, G.R., Fitzgerald, C., Ellwood, A.L., Misri, S., Rurak, D., Riggs, K.W., Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. Pediatr Res 51 (2002), 443–453.
145. Oberlander, T.F., Misri, S., Fitzgerald, C.E., Kostaras, X., Rurak, D., Riggs, W., Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 65 (2004), 230–237.
146. Oberlander, T.F., Grunau, R.E., Fitzgerald, C., Papsdorf, M., Rurak, D., Riggs, W., Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 115 (2005), 411–425.
147. Oberlander, T.F., Warburton, W., Misri, S., Aghajanian, J., Hertzman, C., Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 63 (2006), 898–906.
148. Oberlander, T.F., Reebye, P., Misri, S., Papsdorf, M., Kim, J., Grunau, R., Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med 161 (2007), 22–29.
149. Oberlander, T.F., Bonaguro, R.J., Misri, S., Papsdorf, M., Ross, C.J., Simpson, E.M., Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol Psychiatry 13 (2008), 65–73.
150. Oberlander, T.F., Grunau, R., Mayes, L., Riggs, W., Rurak, D., Papsdorf, M., Misri, S., Weinberg, J., Hypothalamic-pituitary–adrenal (HPA) axis function in 3-month old infants with prenatal selective serotonin reuptake inhibitor (SSRI) antidepressant exposure. Early Hum Dev 84 (2008), 689–697.
151. Oberlander, T.F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S., Devlin, A.M., Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3 (2008), 97–106.
152. Oberlander, T.F., Papsdorf, M., Brain, U.M., Misri, S., Ross, C., Grunau, R.E., Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med 164 (2010), 444–451.
153. Olivier, J.D., Blom, T., Arentsen, T., Homberg, J.R., The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review. Prog Neuropsychopharmacol Biol Psychiatry 35 (2011), 1400–1408.
154. Olsson, C.A., Foley, D.L., Parkinson-Bates, M., Byrnes, G., McKenzie, M., Patton, G.C., Morley, R., Anney, R.J.L., Craig, J.M., Saffery, R., Prospects for epigenetic research within cohort studies of psychological disorder: a pilot investigation of a peripheral cell marker of epigenetic risk for depression. Biol Psychol 83 (2010), 159–165.
155. Ouellet-Morin, I., Wong, C.C.Y., Danese, A., Pariante, C.M., Papadopoulos, A.S., Mill, J., Arseneault, L., Increased serotonin transporter gene (SERT) DNA methylation is associated with bullying victimization and blunted cortisol response to stress in childhood: a longitudinal study of discordant monozygotic twins. Psychol Med 43 (2013), 1813–1823.
156. Parsey, R.V., Oquendo, M.A., Ogden, R.T., Olvet, D.M., Simpson, N., Huang, Y.Y., Van Heertum, R.L., Arango, V., Mann, J.J., Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 59 (2006), 106–113.
157. Patil, A.S., Kuller, J.A., Rhee, E.H., Antidepressants in pregnancy: a review of commonly prescribed medications. Obstet Gynecol Surv 66 (2011), 777–787.
158. Pawluski, J.L., Galea, L.A.M., Brain, U., Papsdorf, M., Oberlander, T.F., Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics 124 (2009), e662–e670.
159. Pawluski, J.L., van, D.E., Abrams, Z., Houbart, V., Fillet, M., Steinbusch, H.W., Charlier, T.D., Fluoxetine dose and administration method differentially affect hippocampal plasticity in adult female rats. Neural Plast, 2014, 2014, 123026.
160. Perroud, N., Zewdie, S., Stenz, L., Adouan, W., Bavamian, S., Prada, P., Nicastro, R., Hasler, R., Nallet, A., Piguet, C., Paoloni-Giacobino, A., Aubry, J.M., Dayer, A., Methylation of serotonin receptor 3A in ADHD, borderline personality, and bipolar disorders: link with the severity of the disorders and childhood maltreatment. Depress Anxiety, 2015.
161. Persico, A.M., Mengual, E., Moessner, R., Hall, F.S., Revay, R.S., Sora, I., Arellano, J., DeFelipe, J., Gimenez-Amaya, J.M., Conciatori, M., Marino, R., Baldi, A., Cabib, S., Pascucci, T., Uhl, G.R., Murphy, D.L., Lesch, K.P., Keller, F., Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci 21 (2001), 6862–6873.
162. Philibert, R.A., Sandhu, H., Hollenbeck, N., Gunter, T., Adams, W., Madan, A., The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 147B (2008), 543–549.
163. Pilowsky, D.J., Wickramaratne, P.J., Rush, A.J., Hughes, C.W., Garber, J., Malloy, E., King, C.A., Cerda, G., Sood, A.B., Alpert, J.E., Wisniewski, S.R., Trivedi, M.H., Talati, A., Carlson, M.M., Liu, H.H., Fava, M., Weissman, M.M., Children of currently depressed mothers: a STAR∗D ancillary study. J Clin Psychiatry 67 (2006), 126–136.
164. Pluess, M., Velders, F.P., Belsky, J., van, I.J., Zendoorn, M.H., Bakermans-Kranenburg, M.J., Jaddoe, V.W., Hofman, A., Arp, P.P., Verhulst, F.C., Tiemeier, H., Serotonin transporter polymorphism moderates effects of prenatal maternal anxiety on infant negative emotionality. Biol Psychiatry 69 (2011), 520–525.
165. Popa, D., Lena, C., Alexandre, C., Adrien, J., Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior. J Neurosci 28 (2008), 3546–3554.
166. Rai, D., Lee, B.K., Dalman, C., Golding, J., Lewis, G., Magnusson, C., Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ, 346, 2013, f2059.
167. Raikkonen, K., Pesonen, A.K., O'Reilly, J.R., Tuovinen, S., Lahti, M., Kajantie, E., Villa, P., Laivuori, H., Hamalainen, E., Seckl, J.R., Reynolds, R.M., Maternal depressive symptoms during pregnancy, placental expression of genes regulating glucocorticoid and serotonin function and infant regulatory behaviors. Psychol Med 45:15 (2015), 3217–3226.
168. Ramchandani, S., Bhattacharya, S.K., Cervoni, N., Szyf, M., DNA methylation is a reversible biological signal. Proc Natl Acad Sci U S A 96 (1999), 6107–6112.
169. Rampono, J., Simmer, K., Ilett, K.F., Hackett, L.P., Doherty, D.A., Elliot, R., Kok, C.H., Coenen, A., Forman, T., Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 42 (2009), 95–100.
170. Rayen, I., Van Den Hove, D.L., Prickaerts, J., Steinbusch, H.W., Pawluski, J.L., Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One, 6, 2011, e24003.
171. Riccio, O., Potter, G., Walzer, C., Vallet, P., Szabo, G., Vutskits, L., Kiss, J.Z., Dayer, A.G., Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6. Mol Psychiatry 14 (2009), 280–290.
172. Risch, N., Herrell, R., Lehner, T., Liang, K.Y., Eaves, L., Hoh, J., Griem, A., Kovacs, M., Ott, J., Merikangas, K.R., Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 301 (2009), 2462–2471.
173. Ross, L.E., Grigoriadis, S., Mamisashvili, L., VonderPorten, E.H., Roerecke, M., Rehm, J., Dennis, C.L., Koren, G., Steiner, M., Mousmanis, P., Cheung, A., Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 70 (2013), 436–443.
174. Roth, T.L., Sweatt, J.D., Annual Research Review: epigenetic mechanisms and environmental shaping of the brain during sensitive periods of development. J Child Psychol Psychiatry 52 (2011), 398–408.
175. Rurak, D., Lim, K., Sanders, A., Brain, U., Riggs, W., Riggs, W., Oberlander, T.F., Third trimester fetal heart rate and Doppler middle cerebral artery blood flow velocity characteristics during prenatal selective serotonin reuptake inhibitor exposure. Pediatr Res 70 (2011), 96–101.
176. Salichon, N., Gaspar, P., Upton, A.L., Picaud, S., Hanoun, N., Hamon, M., De Maeyer, E., Murphy, D.L., Mossner, R., Lesch, K.P., Hen, R., Seif, I., Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci 21:3 (2001), 884–896.
177. Sandman, C.A., Davis, E.P., Glynn, L.M., Prescient human fetuses thrive. Psychol Sci 23 (2012), 93–100.
178. Savelieva, K.V., Zhao, S., Pogorelov, V.M., Rajan, I., Yang, Q., Cullinan, E., Lanthorn, T.H., Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One, 3, 2008, e3301.
179. Schinka, J.A., Busch, R.M., Robichaux-Keene, N., A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol Psychiatry 9 (2004), 197–202.
180. Seckl, J.R., Meaney, M.J., Glucocorticoid programming. Ann NY Acad Sci 1032 (2004), 63–84.
181. Segman, R.H., Goltser, T., Heresco-Levy, U., Finkel, B., Shalem, R., Schlafman, M., Yakir, A., Greenberg, D., Strous, R., Lerner, A., Shelevoy, A., Lerer, B., Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. Pharmacogenomics J 3 (2003), 277–283.
182. Sen, S., Burmeister, M., Ghosh, D., Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 127B (2004), 85–89.
183. Serretti, A., Calati, R., Mandelli, L., De, R.D., Serotonin transporter gene variants and behavior: a comprehensive review. Curr Drug Targets 7 (2006), 1659–1669.
184. Shearman, L.P., McReynolds, A.M., Zhou, F.C., Meyer, J.S., Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta. Am J Physiol 275 (1998), C1621–C1629.
185. Simpson, K.L., Weaver, K.J., de Villers-Sidani, E., Lu, J.Y., Cai, Z., Pang, Y., Rodriguez-Porcel, F., Paul, I.A., Merzenich, M., Lin, R.C., Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci U S A 108 (2011), 18465–18470.
186. Sodhi, M.S., Sanders-Bush, E., Serotonin and brain development. Int Rev Neurobiol 59 (2004), 111–174.
187. Sorensen, M.J., Gronborg, T.K., Christensen, J., Parner, E.T., Vestergaard, M., Schendel, D., Pedersen, L.H., Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol 5 (2013), 449–459.
188. Sundstrom, E., Kolare, S., Souverbie, F., Samuelsson, E.B., Pschera, H., Lunell, N.O., Seiger, A., Neurochemical differentiation of human bulbospinal monoaminergic neurons during the first trimester. Brain Res Dev Brain Res 75:1 (1993), 1–12.
189. Szyf, M., Weaver, I., Meaney, M., Maternal care, the epigenome and phenotypic differences in behavior. Reprod Toxicol 24 (2007), 9–19.
190. Takahashi, H., Nakashima, S., Ohama, E., Takeda, S., Ikuta, F., Distribution of serotonin-containing cell bodies in the brainstem of the human fetus determined with immunohistochemistry using antiserotonin serum. Brain Dev 8:4 (1986), 355–365.
191. Talge, N.M., Neal, C., Glover, V., Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?. J Child Psychol Psychiatry 48 (2007), 245–261.
192. Taylor, S.E., Way, B.M., Welch, W.T., Hilmert, C.J., Lehman, B.J., Eisenberger, N.I., Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol Psychiatry 60 (2006), 671–676.
193. Tissir, F., Goffinet, A.M., Reelin and brain development. Nat Rev Neurosci 4 (2003), 496–505.
194. Tobi, E.W., Goeman, J.J., Monajemi, R., Gu, H., Putter, H., Zhang, Y., Slieker, R.C., Stok, A.P., Thijssen, P.E., Muller, F., van Zwet, E.W., Bock, C., Meissner, A., Lumey, L.H., Eline, S.P., Heijmans, B.T., DNA methylation signatures link prenatal famine exposure to growth and metabolism. Nat Commun, 5, 2014, 5592.
195. Tronick, E.Z., Weinberg, M.K., Depressed mothers and infants: failure to form dyadic states of consciousness. Murray, L., Cooper, P.J., (eds.) Postpartum depression and child development, 1997, Guilford Press, New York, 54–81.
196. Turecki, G., Meaney, M.J., Effects of the social environment and stress on glucocorticoid receptor gene methylation: a systematic review. Biol Psychiatry 79:2 (2016), 87–96.
197. Van den Bergh, B.R., Van, C.B., Smits, T., Van, H.S., Lagae, L., Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 33 (2008), 536–545.
198. Van den Hove, D.L.A., Lauder, J.M., Scheepens, A., Prickaerts, J., Blanco, C.E., Steinbusch, H.W.M., Prenatal stress in the rat alters 5-HT1A receptor binding in the ventral hippocampus. Brain Res 1090 (2006), 29–34.
199. van, I.J., Zendoorn, M.H., Caspers, K., Bakermans-Kranenburg, M.J., Beach, S.R., Philibert, R., Methylation matters: interaction between methylation density and serotonin transporter genotype predicts unresolved loss or trauma. Biol Psychiatry 68 (2010), 405–407.
200. van Kleef, E.S., Gaspar, P., Bonnin, A., Insights into the complex influence of 5-HT signaling on thalamocortical axonal system development. Eur J Neurosci 35 (2012), 1563–1572.
201. Verhaagh, S., Barlow, D.P., Zwart, R., The extraneuronal monoamine transporter Slc22a3/Orct3 co-localizes with the Maoa metabolizing enzyme in mouse placenta. Mech Dev 100 (2001), 127–130.
202. Vesga-Lopez, O., Blanco, C., Keyes, K., Olfson, M., Grant, B.F., Hasin, D.S., Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 65 (2008), 805–815.
203. Wang, D., Szyf, M., Benkelfat, C., Provencal, N., Turecki, G., Caramaschi, D., Cote, S.M., Vitaro, F., Tremblay, R.E., Booij, L., Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS One, 7, 2012, e39501.
204. Warburton, W., Hertzman, C., Oberlander, T.F., A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatr Scand 121 (2010), 471–479.
205. Way, B.M., Taylor, S.E., Social influences on health: is serotonin a critical mediator?. Psychosom Med 72 (2010), 107–112.
206. Weaver, I.C., Cervoni, N., Champagne, F.A., D'Alessio, A.C., Sharma, S., Seckl, J.R., Dymov, S., Szyf, M., Meaney, M.J., Epigenetic programming by maternal behavior. Nat Neurosci 7 (2004), 847–854.
207. Weikum, W.M., Oberlander, T.F., Hensch, T.K., Werker, J.F., Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc Natl Acad Sci U S A 109 (2012), 17221–17227.
208. Weikum, W., Brain, U., Chau, C.M., Grunau, R.E., Boyce, W.T., Diamond, A., Oberlander, T.F., Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age. Front Cell Neurosci, 7, 2013.
209. Welberg, L.A., Seckl, J.R., Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 13 (2001), 113–128.
210. Whitaker-Azmitia, P.M., Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56 (2001), 479–485.
211. Whitaker-Azmitia, P.M., Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?. Int J Dev Neurosci 23:1 (2005), 75–83.
212. Whitaker-Azmitia, P.M., Druse, M., Walker, P., Lauder, J.M., Serotonin as a developmental signal. Behav Brain Res 73 (1996), 19–29.
213. Whitelaw, N.C., Whitelaw, E., How lifetimes shape epigenotype within and across generations. Hum Mol Genet, 2006, R131–R137 15 Spec No 2.
214. Willis-Owen, S.A., Turri, M.G., Munafo, M.R., Surtees, P.G., Wainwright, N.W., Brixey, R.D., Flint, J., The serotonin transporter length polymorphism, neuroticism, and depression: a comprehensive assessment of association. Biol Psychiatry 58 (2005), 451–456.
215. Yadav, D.S., SSRIs and congenital defects. Case registers in pregnancy?. BMJ, 339, 2009, b4286.
216. Yang, H., Sampson, M.M., Senturk, D., Andrews, A.M., Sex- and SERT-associated differences in stimulated serotonin revealed by fast microdialysis. ACS Chem Neurosci 6 (2015), 1487–1501.
217. Yavarone, M.S., Shuey, D.L., Sadler, T.W., Lauder, J.M., Serotonin uptake in the ectoplacental cone and placenta of the mouse. Placenta 14 (1993), 149–161.
218. Zeskind, P.S., Stephens, L.E., Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 113 (2004), 368–375.
219. Zheng, J., Xu, D.F., Li, K., Wang, H.T., Shen, P.C., Lin, M., Cao, X.H., Wang, R., Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons. Int J Clin Exp Pathol 4 (2011), 162–168.